[{"Assets_0_Q2_USD":121014000.0,"CommonStockSharesOutstanding_0_Q2_shares":21098368.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-19425000.0,"NetIncomeLoss_1_Q2_USD":-9195000.0,"NetIncomeLoss_2_Q2_USD":-16090000.0,"StockholdersEquity_0_Q2_USD":71161000.0,"Ticker":"TMDX","CIK":"1756262","name":"TRANSMEDICS GROUP, INC.","OfficialName":"TransMedics Group Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"632779019.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20190808"}]